Back to top
more

Healthways, Inc. (TVTY)

(Delayed Data from NSDQ)

$22.85 USD

22.85
758,329

+0.75 (3.39%)

Updated May 3, 2019 04:00 PM ET

After-Market: $22.85 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

TVTY vs. MEDP: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

TVTY vs. MEDP: Which Stock Is the Better Value Option?

Are Investors Undervaluing Tivity Health (TVTY) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Analysts Estimate Tivity Health (TVTY) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Tivity Health (TVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is Tivity Health (TVTY) a Great Stock for Value Investors?

by Zacks Equity Research

Let's see if Tivity Health (TVTY) stock is a good choice for value-oriented investors right now from multiple angles.

Tivity Health (TVTY) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Tivity Health (TVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why the Earnings Surprise Streak Could Continue for Tivity Health (TVTY)

by Zacks Equity Research

Tivity Health (TVTY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

TVTY vs. PRAH: Which Stock Is the Better Value Option?

by Zacks Equity Research

TVTY vs. PRAH: Which Stock Is the Better Value Option?

Should Value Investors Buy Tivity Health (TVTY) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

TVTY or PRAH: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TVTY vs. PRAH: Which Stock Is the Better Value Option?

Is Tivity Health (TVTY) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Company News For Dec 11, 2018

by Zacks Equity Research

Companies In The News Are: TVPT,ACB,LIN,NTRI,TVTY

Tivity Health (TVTY) Tops Q3 Earnings Estimates

by Zacks Equity Research

Tivity Health (TVTY) delivered earnings and revenue surprises of 5.36% and -1.32%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Healthcare Q3 Earnings Due on Nov 5: ACHC, THC, BKD, TVTY

by Zacks Equity Research

Players in the healthcare industry should gain from an increase in revenues, partly offset by a rise in operating costs.

Tivity Health (TVTY) Q3 Earnings Preview: What to Know Ahead of the Release

by Zacks Equity Research

Tivity Health (TVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tivity Health (TVTY) Matches Q2 Earnings Estimates

by Zacks Equity Research

Tivity Health (TVTY) delivered earnings and revenue surprises of 0.00% and -0.47%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

    Express Scripts (ESRX) Soars: Stock Adds 8.6% in Session

    by Zacks Equity Research

    Express Scripts (ESRX) shares rose nearly 9% in the last trading session, amid huge volumes.

      Zacks.com featured highlights include: Caterpillar, Cinemark, Healthways, Boeing and Concho

      by Zacks Equity Research

      Zacks.com featured highlights include: Caterpillar, Cinemark, Healthways, Boeing and Concho

        Why Teladoc (TDOC) Stock Has More Than Doubled in a Year

        by Zacks Equity Research

        Teladoc (TDOC) continues to gain from high demand for its telehealth services.

          Humana Extends Contract With Tivity Health, Spurs Healthcare

          by Zacks Equity Research

          Humana (HUM) continues to form strategic partnerships to improve the overall health of its Medicare Advantage members.

            Teladoc Rides on Growing Demand for Telehealth Services

            by Zacks Equity Research

            Rising demand for telehealth services is likely to create long-term growth opportunities for Teladoc's (TDOC).

              BioTelemetry, Inc. (BEAT) in Focus: Stock Moves 6.5% Higher

              by Zacks Equity Research

              BioTelemetry (BEAT) was a big mover last session, as the company saw its rise nearly 7% on Friday amid huge volumes.

                NovoCure (NVCR) Jumps: Stock Rises 10.5%

                by Zacks Equity Research

                NovoCure (NVCR) was a big mover last session, as the company saw its shares rise over 10% on the day.

                  Ensign Group (ENSG) Continues to Grow on Inorganic Path

                  by Zacks Equity Research

                  The Ensign Group, Inc. (ENSG) has acquired the real estate and operations of three skilled nursing and one intermediate care facilities across Idaho and Utah.

                    Can the Rally in Tivity Health (TVTY) Shares Continue?

                    by Zacks Equity Research

                    Tivity Health Inc (TVTY) has been on the move lately as the stock has risen by 12.8% in the past four weeks, and it is currently trading well above its 20-Day SMA

                      Healthcare Earnings to Watch on Feb 23: ACHC, SEM & More

                      by Zacks Equity Research

                      We take a sneak peek at two healthcare stocks scheduled to report fourth-quarter figures on Feb 23.